Protalix BioTherapeutics
PLX
#8911
Rank
HK$1.09 B
Marketcap
HK$13.62
Share price
1.74%
Change (1 day)
7.37%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total assets

Total assets on the balance sheet as of June 2025 : HK$0.61 Billion

According to Protalix BioTherapeutics 's latest financial reports the company's total assets are HK$0.61 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Protalix BioTherapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$0.56 B-13.57%
2023-12-31HK$0.65 B51.29%
2022-12-31HK$0.43 B-24.12%
2021-12-31HK$0.57 B9.07%
2020-12-31HK$0.52 B48.97%
2019-12-31HK$0.35 B-26.15%
2018-12-31HK$0.47 B-15.15%
2017-12-31HK$0.56 B-11.54%
2016-12-31HK$0.63 B-15.39%
2015-12-31HK$0.75 B24.02%
2014-12-31HK$0.60 B-30.84%
2013-12-31HK$0.87 B44.02%
2012-12-31HK$0.61 B51.66%
2011-12-31HK$0.40 B-20.12%
2010-12-31HK$0.50 B-34.16%
2009-12-31HK$0.76 B94.85%
2008-12-31HK$0.39 B-26.09%
2007-12-31HK$0.53 B153.1%
2006-12-31HK$0.20 B274.7%
2005-12-31HK$56.01 M1173.56%
2004-12-31HK$4.39 M-22.72%
2003-12-31HK$5.69 M-16.62%
2002-12-31HK$6.82 M-14.45%
2001-12-31HK$7.97 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amicus Therapeutics
FOLD
HK$6.76 B 1,006.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$33.20 B 5,334.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.624 T 265,846.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$310.26 B 50,681.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel